ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
scaffold_2_277 # 256211 # 256564 # -1 # ID=2_277;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.435	scaffold_2_277 	256211	256564	-	Strict	2090	23.0978	smeB	100.0	3003052	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACGTTCTCCGTGCTGGCAAGAAATACTAGATGGGTGGGATCTGGATCGGCTTGCGCTGAATGTGGTCTTTTTATTGCGAATGAGATCAGTGTTATATTGGGGTGGAGCTGGGTTCATAGCTACGTCTCAATGAAAGAACAAATCCCCAAATGTTCCTTTGTTAGATGGCATTTGCCAGGAGCATTTTACTTTCATGGCAAATCAAATTTTGAATGGATGGTAGTTGAGGAAGGTGGTTTGAATTTATCTGGGAAAGCGCAAGTGAGCATGATGCAAGTGCATCACGTCCCAGCGCCATCTCCATCTTCATCATACCAAAAACATACGTCTCTCTCTTTTGGATCTTCATAA	MTFSVLARNTRWVGSGSACAECGLFIANEISVILGWSWVHSYVSMKEQIPKCSFVRWHLPGAFYFHGKSNFEWMVVEEGGLNLSGKAQVSMMQVHHVPAPSPSSSYQKHTSLSFGSS	MVRFFIDRPIFAWVIAIAVSLLGLLAILILPVDRYPQIAPPTITIRATYTGASSQTVENAVTQVIEQSQQSLDHLMYMTSTSASDGSAQVNLVFATGTNPDTAQVQVQNQLQAAMATLPQAVQQNGLTITKSSGSIFEVLSFTSEDGSMDNFDVANFMEARIDDQISRVSGVGNIQPIGQEYAMRIWLDPEKMRQYALMPWDIETALQAQNTDVSAGELGGQPALKGQQLDATVTARSRLHTPEQFAQVVLKADANGSVVRLGDVAKIGLGPESYDSISTFNGKPSASLGIELNAGANAIAVSKAIDARLQQLQKYWPHGYTAHVAFTTTPFVTISLKEVVITLIEAIILVVLVMYLFLQNWRATLIPTIAVPVVLLGTFGVLAAFGYSINTLTMFALVLAIGLLVDDAIVVVENVERVMTFEGLAPKPATLKAMGQITGALVGIVLVLTAVFLPMAFFSGVTGVIYRQFSVTIAAAMILSVLVAMTITPALCGSILHQIPKGGHPHGDHGGEPSLLGKFFIWFNHRFERTSNGLRHRVDRFLGRRTLGVLFYLVLSVATGLLLWHLPGAFLPDEDQGMLNALVKLPAGSTLEQTRAVMDRLSAVAVKDDGVLSIQATAGFSVTGSGQNVGQAFIRLKDWDDRKDDADTIAARLTRAMASVPDAQVFITSPPAILGLGDAGGFTLELQDEGGAGHAAAVAARNTLLKEAAKDPKLVNVRYASLEDAPVYAVKVDDAKAQAMGVNPQDVNDTLNAALGGDFVNNFIYKGRIKKVFIQGTAEARMQPQDIERWSVRNQAGQMVPLSSLISTHWTSAPAAVQRYNGISAMEITGQPAPGVSSGEAMAEIARLADTLPEGFSHAWSDMAYQEQLSGNQAPMLYAISLLFVFLCLAALYESWAVPFAVMLAVPVGMFGAVLMMNLRGLNNDVYFQVGLLTTIGLAAKNGILIVEFARILEQQGKSTREAILQAVYLRLRPIVMTSLAFLMGVLPLVFATGAGSAARRSLGTGVAGGTVASMVLGMFFVPLFYLLVRRLFPGRAPADATVPETSP	11.15	gnl|BL_ORD_ID|1854|hsp_num:0	1960	True	loose hit with at least 95 percent identity pushed strict
scaffold_2_1454 # 1333992 # 1334138 # -1 # ID=2_1454;partial=00;start_type=ATG;rbs_motif=AGxAG;rbs_spacer=5-10bp;gc_cont=0.388	scaffold_2_1454 	1333992	1334138	-	Strict	500	20.4014	mphH	100.0	3004539	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGAATCTGAGGATGGTGGATAGAGCCATGAGATGCTTGCATAAAAAGTCGAGGTTTAATAATGATTGTTCAGTTCATATCACTGTTTATATTCACGATGATGAAGTCCAATGGCGTCATGGCTTGGATTTAGATCATAGGCCATGA	MNLRMVDRAMRCLHKKSRFNNDCSVHITVYIHDDEVQWRHGLDLDHRP	MPEDLDALLDLAARHGLDLDGGTLRTEEIGLDFRVAFARAHDGGDWVLRLPRRPDVLERAAVEGRLLAMLAPHLDVAVPDWRISTSELIAYPLLPGSPGLTVAADGEVSWHVDMASTVYARSLGSVVAQLHAVDAEAAAATGIEVRSPAQVRGAWRQDLARVGAEFEIAPALRERWEAWLADDGCWPGHSVLTHGELYPAHTLVEDERITAVLDWTTAAVGDPAKDLMFHQVSAPSAIFEVALQAYAEGGGRPWPGLARHCTEMFSAAPLGYGLYALATGEAAHREAAAAALNPPEER	16.11	gnl|BL_ORD_ID|2751|hsp_num:0	3216	True	loose hit with at least 95 percent identity pushed strict
scaffold_2_2497 # 2287836 # 2287949 # 1 # ID=2_2497;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.491	scaffold_2_2497 	2287836	2287949	+	Strict	1000	21.9422	MCR-1.4	100.0	3004515	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	ATGAAGTTACTTTCATGGTCTCAAGTGAGGTTGAAAGAGTCGGGCCGTGCGGCCGCGTCGCAGCGGCCTATGTCAGAAGACAAGCTTCCGAAAGCACAATTTCTTACTATTTAG	MKLLSWSQVRLKESGRAAASQRPMSEDKLPKAQFLTI	MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFGAMLLITTLLSSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDLLNAAFIMRIIGLGVLPSLLVAFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYASFFRVHKPLRSYVNPIMPIYSVGKLASIEYKKASAPKDTIYHAKDAVQATKPDMRKPRLVVFVVGETARADHVSFNGYERDTFPQLAKIDGVTNFSNVTSCGTSTAYSVPCMFSYLGADEYDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLPKAQFADYKSATNNAICNTNPYNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKFTPVCEGNELAKCEHQSLINAYDNALLATDNFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGMPNAFAPKEQRSVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFIR	6.84	gnl|BL_ORD_ID|2739|hsp_num:0	3143	True	loose hit with at least 95 percent identity pushed strict
scaffold_2_2732 # 2508717 # 2508920 # -1 # ID=2_2732;partial=00;start_type=GTG;rbs_motif=4Base/6BMM;rbs_spacer=13-15bp;gc_cont=0.495	scaffold_2_2732 	2508717	2508920	-	Strict	1000	21.9422	MCR-4.1	100.0	3004325	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	GTGTGGTACATTTTTGTGTTTTCGAAGTTGGGGTGTTTTTCGTTTTTGGATTGGAATGGGAATGGGAGGTTGAATTTGGGTTTGGGTTTCGAGGGTGGAGAGGAGGAGTGTGAGGGCAATGAGGAGCGAGAGAGAAAGGGGTTCCGGAGTGGAGTCCAGGGTGGATTTGCGAGTGGGTTTGATAATGATTCGGGATGTGGTTGA	MWYIFVFSKLGCFSFLDWNGNGRLNLGLGFEGGEEECEGNEERERKGFRSGVQGGFASGFDNDSGCG	MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALSFLFSIFTVKYLLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHPAEALMYVNLASITNLLLTGLLPSYLIYKADIHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFVRNNSELRRYIVPTYFVSSASKYLNEHYLQTPMEYQQLGLDAKNASRNPNTKPNLLVVVVGETARSMSYQYYGYNKPTNAHTQNQGLIAFNDTSSCGTATAVSLPCMFSRMGRADYDPRRANAQDTVIDVLSHSGIKVQWFDNDSGCKGVCDQVENLTIDLKSDPKLCSGQYCFDQVLLNKLDKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCSQEELINTYDNTILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVPMLAWVSNDFSQDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCRY	12.38	gnl|BL_ORD_ID|2521|hsp_num:0	2848	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_385 # 398786 # 399016 # -1 # ID=3_385;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.532	scaffold_3_385 	398786	399016	-	Strict	545	22.3274	OXA-443	100.0	3003599	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGGTTGAGCCTACGCGCGCGGACATGTTGAGCCATGTGGCGTGGGGTGGGAGACCTTGGTTGTTTGTTGATGAGGGAGAGGAGGAGGAGGAAGAGGGGAATAAAGAGGTAGATTTCTTGGGCAGGAAAGGGATGAAGTGTTTTGCGAGGAGCATGGGGCCGATGGTGTTTACTTGGAATGTGTGCAGGAGTTGTTCTTGGGATACTTGCGTGGGTGATTTTTCCGGGTAG	MVEPTRADMLSHVAWGGRPWLFVDEGEEEEEEGNKEVDFLGRKGMKCFARSMGPMVFTWNVCRSCSWDTCVGDFSG	MTKLRHATTGAFLAALATFAHAEHPVCTLVADAATGKVVLQEGKCNERVTPASTFKLALAVMGYDAGFLKDPHTPVEHFRRGDPDWGGRPWRQPVDPTLWLKYSVVWYSQRITHAMGAQMFASYVRKLDYGNMDVSGDPGKNNGLDRSWITSSLKISPEEQVGFLRRLVNRQLPVSAQTYEMVDRTVQTWQVPGGWAVQGKTGTAGPAPGNTSADGTWDQAHAYGWFVGWAKKGGRTYVFANLIQDDKIEPTSGGIRSRDAMLARLPQVLAAAKP	27.64	gnl|BL_ORD_ID|2323|hsp_num:0	3513	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_417 # 418910 # 419140 # 1 # ID=3_417;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.532	scaffold_3_417 	418910	419140	+	Strict	500	21.9422	OXA-379	100.0	3001565	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGGATGGGAATGGGATGTGGGCATCGCTCATTGGAGTGTTCGTGAAGGTGTGTTTCTGATTGATGTTCATTCATCGACTCCAAACCGTCCCCATTGCCAGCCAGATGCGCATCTCCTGCTCTCCTCGAAAACCCTCGTCCCGGGTATTGTGTGTAGGGCATTCGTGGAGCATGGAGACGCTGGAAACTGTATCCCCGTCAAACACGATCTAGACCTGGCCATGAGCTGA	MGWEWDVGIAHWSVREGVFLIDVHSSTPNRPHCQPDAHLLLSSKTLVPGIVCRAFVEHGDAGNCIPVKHDLDLAMS	MNIKALLLITSAIFISACSPYIVTANPNHSTSKSDEKAEKIKNLFNEAHTTGVLVIQQGQTQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTLGDAMKASAIPVYQDLARRIGLELMSNEVKRIGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWEWDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL	27.74	gnl|BL_ORD_ID|1792|hsp_num:0	1898	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_790 # 761030 # 761227 # 1 # ID=3_790;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.424	scaffold_3_790 	761030	761227	+	Strict	750	23.0978	floR	100.0	3002705	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAGTATGTTATTGAGGAGAGGTGTTATTGATGGGGAGAAGATTCACAGATGTGGGGTTGAAGGAAAAAAAGAAATCAAGTGGTTGTTAACGTTCTGGCACGAGACCAGGCCGCTACAAGCATTCACCAATTCCTCACCCCGCTTCTATTTTGTGGATTTGGCCAAAGCTATGAAATATACTACCTGTGTCACATAA	MSMLLRRGVIDGEKIHRCGVEGKKEIKWLLTFWHETRPLQAFTNSSPRFYFVDLAKAMKYTTCVT	MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMVMLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAMLVATFATVRDVYANRPEGVVIYGLFSSVLAFVPALGPIAGALIGEFLGWQAIFITLAILAMLALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLIGQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCVARGMALLVCGAVLLGIGELYGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAGSAVAFYFCVQSLIVSIVGTLAVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV	16.09	gnl|BL_ORD_ID|2373|hsp_num:0	522	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_1780 # 1672052 # 1672189 # 1 # ID=3_1780;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.377	scaffold_3_1780 	1672052	1672189	+	Strict	1200	21.557	tetS	100.0	3000192	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGCAGACGGCTACAAGAGCAACCATGATAGTAGCGAACTTCATTGTAAGATATTCTATGTAGATGGATTATATGGTTGGAAATTGTGTTATGCAAATGAGCAAGTGAGCAAGATATGGCAACAATCGGGATATTAA	MADGYKSNHDSSELHCKIFYVDGLYGWKLCYANEQVSKIWQQSGY	MKIINIGILAHVDAGKTTLTESLLYSSGAIKELGSVDSGTTKTDTMFLERQRGITIQTAITSFQRENVKVNIVDTPGHMDFLADVYRSLSVLDGAILLISAKDGVQSQTRILFHALRKMNIPIIFFINKIDQNGINLPDVYQDIKDKLSDDIIIKQTVNLNLKPYVIDYTEPEQWETVIVGNDYLLEKYTIGKTLNIAELEKEENERIQSCSLYPVYHGSAKNNIGIKQLIEVITSKLFSPTQLNSDKLCGNVFKVEYSDDGQRLVYVRLYSGTLHLRDSVNISEKEKIKVTEMYTSINGELRQIDKAEPGEIIILKNELLKLNNVLGDKKRLPHREILENPLPMLQTTIEPCKSVQREKLLDALFEISDSDPLLQYYVDTVTHEIVLSFLGEVQMEVTCTLIQEKYHIEIETRKPTVIYMERPLKKSEFTIDIEVPPNPFWASIGLSVTPLPLGSGIQYESLVSLGYLNQSFQNAVMEGIRYGCEQGLYGWKLTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQAFRKSGTELLEPYLSFEIYVPQEYLSRAYNDASKYCANILNTKLKGNEVILIGEIPARCIQEYRNSLTFFTNGRSVCLTELKGYQVTNIKSAFQPRRPNNRIDKVRHMFNKINLH	7.02	gnl|BL_ORD_ID|1461|hsp_num:0	1553	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_2585 # 2442916 # 2443029 # -1 # ID=3_2585;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.447	scaffold_3_2585 	2442916	2443029	-	Strict	300	19.631	AAC(3)-VIIIa	100.0	3002542	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGGAGACGTTTGGAATTGAGGATTCTTCGAGTGGCAGAAGGGTATGGCGTGTATGCAATTATATTCAGAATGATACACAGGGGTATATCGATGGCAATGGGAATTGGGATTGA	METFGIEDSSSGRRVWRVCNYIQNDTQGYIDGNGNWD	MDEKELIERAGGPVTRGRLVRDLEALGVGAGDTVMVHTRMSAIGYVVGGPQTVIDAVRDAVGADGTLMAYCGWNDAPPYDLAEWPPAWREAARAEWPAYDPLLSEADRGNGRVPEALRHQPGAVRSRHPDASFVAVGPAAHPLMDDHPWDDPHGPDSPLARLAGAGGRVLLLGAPLDTLTLLHHAEARAEAPGKRFVAYEQPVTVGGRRVWRRFRDVDTSRGVPYGRVVPEGVVPFTVIAQDMLAAGIGRTGRVAAAPVHLFEAADVVRFGVEWIESRMGGAAGGA	12.94	gnl|BL_ORD_ID|471|hsp_num:0	501	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_40 # 44370 # 44717 # -1 # ID=4_40;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.460	scaffold_4_40 	44370	44717	-	Strict	700	22.7126	vanSN	100.0	3002940	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	GTGAGTAAGCGTCCTCCTGATTTGCTCTTTATCCTAAGTGAAGTGATACATAAATCCTCGATATTTCAAATGTGCTCTGGCAGCTGCTCGTGTAAAGTAAAGACAGGTTCGGTGATGCCAAATACTTATACCCCTTGGAGATTGGACGCGCTTTTGCCAGCCAAGCAGCACGCCTACGAGGATCGTTGCCAGTTCTGGAAATGTGCCACTAACGAAACACATACTTTGCCGTCTCTTTTTTTTTTGGCCCAGAGAGCATGTATGGTTCAAGCCAGTCCAGTCCTGTTAGGATGGTTAATGCAGTTGACGGCTACACTTCTTTCTTACTTAGATAGGTCGTGCCCCTAG	MSKRPPDLLFILSEVIHKSSIFQMCSGSCSCKVKTGSVMPNTYTPWRLDALLPAKQHAYEDRCQFWKCATNETHTLPSLFFLAQRACMVQASPVLLGWLMQLTATLLSYLDRSCP	MKNKLNDPLIKRILLRYVSTVLLAIGIYGGVLLLLLFLFRLRTWYGDEPFYLFLRTLYIRFNLIGLVSSGAFLLLLMITLVYIFKLIGYLNETITATKQLLEAPEQRIQLSTELFTVQEEMNQIRENNNQANRAAKVAEQRKNDLIVYLAHDLRTSLTSVIGYLTLLKEEPQISTELRAKYTDIALDKALRLEELIGEFFEVTQFNLTKLTINKEIVDLSIMLEQISYEFLPILNEKGLKWQLAIDKGIKAEVDPNKMGRVFDNLIRNAINYSFSNSTIHLSLEKNGQNLELKITNETHTLPEEKLTQIFEPFYRVDTSRSSSTGGTGLGLSIVKDIVEASGGRIHAQSSNNQMTFTLTLPISE	31.59	gnl|BL_ORD_ID|975|hsp_num:0	1033	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_137 # 120134 # 120235 # -1 # ID=4_137;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.529	scaffold_4_137 	120134	120235	-	Strict	500	19.2458	OXA-21	100.0	3001416	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGATGGATTTGGGCTGGGAGGGAAGAATGGAAGGCAGATGTGTGGTGAGGTGGGAAGGGCTGCTAGTTATGGGGGATGAAGGAAGGAAAGACGGGGTTTAA	MMDLGWEGRMEGRCVVRWEGLLVMGDEGRKDGV	MAIRIFAILFSTFVFGTFAHAQEGMRERSDWRKFFSEFQAKGTIVVADERQTDRVILVFDQVRSEKRYSPASTFKIPHTLFALDAGAARDEFQVFRWDGIKRSFAAHNQDQDLRSAMRNSTVWIYELFAKEIGEDKARRYLKQIDYGNADPSTSNGDYWIDGNLAIAAQEQIAFLRKLYHNELPFRVEHQRLVKDLMIVEAGRNWILRAKTGWEGRMGWWVGWVEWPTGPVFFALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVNSDAAR	12.00	gnl|BL_ORD_ID|197|hsp_num:0	213	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_423 # 368027 # 368200 # -1 # ID=4_423;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.603	scaffold_4_423 	368027	368200	-	Strict	450	21.1718	HMB-1	100.0	3004092	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	HMB beta-lactamase	ATGGATCTGGTGGGGAAGATTCTACGAATGGGCGCGGGCTGGATGCTGTGCTTCCCTGGCGAGGAGCTGAGGTTGGTGGCAGGGCAGAGGGTGTTTGTCGACGGGAAGGACGCGTGCTTCGCATGTAGGGTGTGGGTGTTGCGTGGTGGGAAGAGGAAGTTGTGCCTGCACTGA	MDLVGKILRMGAGWMLCFPGEELRLVAGQRVFVDGKDACFACRVWVLRGGKRKLCLH	MKIHLWISLGLLLLTNIVLAEEPLPELEVKKIDEGVYLHTSYENYPSWGLVASHGLVFVDGKDAYIIDTPATVKDTEVLVQWINDQGFKPKASISTHFHDDSTIGIAYLNSKSIPTYASEQTNELLNKEVAAQATHSFKKNPYWLLKNKIEAFYPGAGHTPDNLVVWLPKQKILFGGCFVKPEGLGNLSHAVVSEWPASAEKLINRYSDAKIVVPGHGTMGDASLLEKTKQRALEAVAKKK	23.65	gnl|BL_ORD_ID|2441|hsp_num:0	2753	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_821 # 712787 # 712972 # 1 # ID=4_821;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.548	scaffold_4_821 	712787	712972	+	Strict	550	21.1718	CKO-1	100.0	3004773	protein homolog model	n/a	n/a	penam	antibiotic inactivation	CKO beta-lactamase	ATGGGAGGAGAGGAGAGGAGAGGAGATCTGCGTGGTGGTGCTTGCTTCTCCGATCGGGTAGGTGAGGGATGGCTGTCTGACAGGGAGGTGATTGGTGTGGGCGGCAGAGCTCGAGGGGAAGAGAGATTTCCGGGGAGATCTATGGAAGTGTTTATTGTTGGATTGAGGATCTTGGTGAGTGAGTGA	MGGEERRGDLRGGACFSDRVGEGWLSDREVIGVGGRARGEERFPGRSMEVFIVGLRILVSE	MRNEEVISMWQRMKWGLCVLAALSGSAMAAPLTAQYVSAIAMQEEQRLHARIGIAVLDTATNSITHYRGEERFPLNSTHKPLLCAALLREVDRKALALSASMQFEPSQLVEYSPITEKHVAPDAMSWAQLCSAAVSYSDNTAANLIARKLNGPQAVTQFLRDSGDTITRLDRYEPELNSAIPGDERDSTTPVAIAQTLNTLLLGNVLQPSSREQLMQWMRDDKVADGLLRSVLPDGWKIADKTGAGDNGSRSIVSVVWPTSQKPLLVVIYITQTPATMAQRDAAIVRIGESLFSTLAVYD	20.33	gnl|BL_ORD_ID|2663|hsp_num:0	3574	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_1423 # 1284279 # 1284515 # 1 # ID=4_1423;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.515	scaffold_4_1423 	1284279	1284515	+	Strict	1650	22.7126	Listeria monocytogenes mprF	100.0	3003770	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGGCTAGCATAATCCGTATCTTCACCTCAAGCGACACAGCCGAGATCAAGGGGCAATTAAAAGAGATTGTCTCGTCGACGGATAGACTGGGATTGATCCACGAGAGTGTTAATTCTTTTGACGAGGGCGTGTGGACGAGGCAGTGGTTTAGTTGGGCGAATGGGCTTTTTGGTCAGTGTTTGTTGGATCTGAGGGATAGGGGGTTCGGGGGCGTTTTGGGCGCGAGCTACCAGTGA	MASIIRIFTSSDTAEIKGQLKEIVSSTDRLGLIHESVNSFDEGVWTRQWFSWANGLFGQCLLDLRDRGFGGVLGASYQ	MKEKLMQAYAWFQKNSTVVKIVFITFVMAFVIFEIINIATGIDYPSLKENLTSQSPEQIFIMFIVGLIAVTPMLLYDYVIVKLLPGKFSPSHVIASGWITNTFTNIGGFGGVLGASLRASFYGKNASHKEILLAISKIALFLVSGLSIYCLVSLATLLIPGFADHFVNYWPWLLAGGLYFPILFTITKWKSKSLFVDLPIKRELTLIIASLLEWGFAFGCFAIIGTLMGEPVDIFKVFPLFVIASVIGIASMVPGGVGTFDVVMILGLSQLGVSQELALAWMLFYRIFYYIIPFVVGLLFFVQKAGKKVNDFLEGLPLLFLQKVAHRFLVIFVYGSGLLLILSSAVPNAIYHVPFLYKIMPFNFLFTSQITIVAFGFLLLGLARGIECKTKKAYIITVIVLGCAIFNTLARVFSMKQAIFLGIVLLCLFLARNEFYREKLVYTWSKVIIDSIIFIVCLAGYIVIGIYNSPNIKHSKEIPDYLRIASEHLWLVGFVGVFIAVVSLVIIYIYLSTTKEKLGSPFEAVKVREHLAKWGGNEVSHTMFLRDKLLFWAAEGEVLFSYRIIADKMVIMGEPTGNMDKMEAAIEEVMMNADRFGYRPVFYEVRGTMIPYLHDHGFDFIKLGEEGFVDVQNFTMSGKKKKGERALMNKLEREGYTFEIIEPPFNHDTWTTLRAVSDEWLDGREEKGFSLGFFDTYYLEQAPIAIAKNGEGTIVGFASMMPSYTDEMTSIDLMRYSKEAPSGIMDFLFINLFEKAKEDGFQTFNAGMAPLANVGESKYAFLGERLAGLVYRYSQGFYGFKGLRNFKSKYVTEWEQKFVAFRKRSSIAFTMLQLMILVGKKRPLANSQVVLDFPLEEETKKPDSE	9.02	gnl|BL_ORD_ID|2108|hsp_num:0	2279	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_2280 # 2123994 # 2124245 # 1 # ID=4_2280;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.456	scaffold_4_2280 	2123994	2124245	+	Strict	350	21.9422	Bacillus clausii chloramphenicol acetyltransferase	100.0	3004452	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGCGAAATATCGATATTGAGATGACACAAATTGCTGCAAGTCGTAAGCAGCTTCAAGGCGATTTCCTGCTCCCTATTATTGGTCAATTGCACCGTAATGGACTTGATGCATCTTCGTTTTTGTCGCCCGATTCGGAACAGGAAAATACCAAAGTGGTGCGGTCTTCGGATTCTAAACGTGTTCAGGCATATGGAACAAGGCTCCGGCGTCTATCAACTGCGAGACTCTCTTGCAGTTTACGGATAGAGTAG	MRNIDIEMTQIAASRKQLQGDFLLPIIGQLHRNGLDASSFLSPDSEQENTKVVRSSDSKRVQAYGTRLRRLSTARLSCSLRIE	MEILTLLIRDTMGSKRIFLNPYFQQQPTFSLTNEINITILMKNLKKKHYKLYPAFIFMVTKIVNAHREFRINFNSEGNLGYWTEICPLYTIFDNKSHTFSGIWSPNLTIFSEFHSKYENDAERYNGTRRLFPKKPIPDNPIPISMIPWSSFTAFNLNINNGGDFLLPIITGGKYSQVNDELFLPVSIQNASCLFVMATMQSVFINDLQNLVDESEDWIYLVVSDEWYY	36.40	gnl|BL_ORD_ID|2565|hsp_num:0	2891	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_2281 # 2125859 # 2125993 # 1 # ID=4_2281;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.393	scaffold_4_2281 	2125859	2125993	+	Strict	400	20.4014	VIM-7	100.0	3002277	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	VIM beta-lactamase	ATGTTGACTGAATCATCAGATTGTGGTATGACACATTTTCATGATGATGATTTCAGGAAATCGCTGCTTGGAATTTCTCCTCAGGATAAGTCATCGATTGAGACTACTAAATTTGGGGAGATTGCTGGCTCGTAA	MLTESSDCGMTHFHDDDFRKSLLGISPQDKSSIETTKFGEIAGS	MFQIRSFLVGISAFVMAVLGSAAYSAQPGGEYPTVDDIPVGEVRLYKIGDGVWSHIATQKLGDTVYSSNGLIVRDADELLLIDTAWGAKNTVALLAEIEKQIGLPVTRSISTHFHDDRVGGVDVLRAAGVATYTSPLTRQLAEAAGNEVPAHSLKALSSSGDVVRFGPVEVFYPGAAHSGDNLVVYVPAVRVLFGGCAVHEASRESAGNVADANLAEWPATIKRIQQRYPEAEVVIPGHGLPGGLELLQHTTNVVKTHKVRPVAE	16.60	gnl|BL_ORD_ID|1944|hsp_num:0	2061	True	loose hit with at least 95 percent identity pushed strict
scaffold_5_322 # 323844 # 323942 # -1 # ID=5_322;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.576	scaffold_5_322 	323844	323942	-	Strict	550	19.2458	OXA-265	100.0	3001721	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGCTGAGAGGAGTGGTTGGTGGACGGGGAGGAAAGTGAGTTTGTTGGTGGGGAGGATTCAGGAGAGAGAGCTTGGTCCGCCGCGATTGGGTAGGTAG	MAERSGWWTGRKVSLLVGRIQERELGPPRLGR	MKLSKLYTLTVLIGFGLSGVACQHIHTPVSFNQIENDQTKQIASLFENVQTTGVLITFDGQAYKAYGNDLNRAKAAYIPASTFKILNALIGIEHDKTSPNEVFKWDGQKRAFESWEKDLTLAEAMQASAVPVYQALAQRIGLDLMAKEVKRVGFGNTRIGTQVDNFWLIGPLKITPIEEAQFAYRLAKQELPFTPKTQQQVIDMLLVDEIRGTKVYAKSGWGMDITPQVGWWTGWIEDPNGKVIAFSLNMEMNQPAHAAARKEIVYQALTQLKLL	11.64	gnl|BL_ORD_ID|2401|hsp_num:0	3432	True	loose hit with at least 95 percent identity pushed strict
scaffold_6_1264 # 1069055 # 1069192 # -1 # ID=6_1264;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.507	scaffold_6_1264 	1069055	1069192	-	Strict	1650	20.7866	Brucella suis mprF	100.0	3003772	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGAAGTCGGACCAAGCTACCAAAGCGGCTGACAGACCAATTGCTGGACCGTTTAGGGCTGCCACAAGGATCTTGGGGTGGTGTGCGAATGCATCCGTGATGTTGAGATTGTTCGAAACGAAGGATTTGAGCCAATGA	MKSDQATKAADRPIAGPFRAATRILGWCANASVMLRLFETKDLSQ	MLWWDDISMSLIDDEIPSSQPQVSGRHFGWLKQYQHFLFPIAGIAIALLAIYVLENLLRHTSRTETLAALHNISWTTLALAVFFTALSYAAVALYDVVAVDTIAPNQIPRRIAAVAGAAGYAISNALGFSLLTGGALRYRIYAAEGISLADIGKIVGTSWFAIWFALIIMVGAALLIDPQDVPFLSAIDIRIDIVAGILILGGIGWLIYWLSHGERNVSIGSFSLRLPNSKGALTQIFAGVVDVGAAAATLYVLLPEGAVPSFAVFALVYVIAIVLGIASHAPGGLGAFEATIIAGLGLGGKPDAIAGLLAYRLIYTVLPLVVATAGILIWEVMRRRHMLDKQARFAKRLVEPLVPGLSASIIFLGGIILLISGATPDMRYRVKLLSDIVPEFLVEMSHLAASLVGVALLIVARGLSKRLERAWVAAMVLLLCGAVFSIAKGLDWEEASILCLFALSLWGFRDSFYRRPIAGPFELSWNWIATVGTTVLVSTWLGFFVYRHIEYSSDLWWDFAWNGNAPRFLRATVLVFAVVAAVGLHSIINRHGQRRRKVDHSIPDAVPALVARCPHTDAALAMLGDKQFLLAPDDSAFIMYAQSGGSLIALGEPIGDAEAGKELAWSFHSLADRLALRTVFYGVGPQSLPLFLDMGLIALKLGEVARVDLTDFSLEGPRRQPFRYADRKVDKDGLTFEIIPAADVPPLIPRLRAISDAWLDHKSGSEKGFSLGYFNDEYLKRFDIAVLKKDGEIVAFANIWRGADKYEITVDLMRYMPNVHKLLMDALFAKLLTFSKQEGYKWFNLGAAPLSGLSGSRLASRWNRFGSFIYRRGADLYHFDGLKAFKEKFDPVWTPHYMVCPGGLETPRALLDATTLINGSPLEFIRK	5.11	gnl|BL_ORD_ID|2109|hsp_num:0	2281	True	loose hit with at least 95 percent identity pushed strict
scaffold_6_1714 # 1463489 # 1463638 # -1 # ID=6_1714;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.493	scaffold_6_1714 	1463489	1463638	-	Strict	1900	20.7866	AcrF	100.0	3000502	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGCACAAGACATTGTCCAATTATAAGGCTCCGTCGGATGGCTTTGTCATACCCTTCCTGACTCATCAGGAGCCTCAGGGGAAAATCGATCACAAGGCCGAGTTTGAGATTGAGACTCCACAAGAGGATCGGGAGAGAGAGAGTGTGTGA	MHKTLSNYKAPSDGFVIPFLTHQEPQGKIDHKAEFEIETPQEDRERESV	MANFFIRRPIFAWVLAIILMMAGALAILQLPVAQYPTIAPPAVSVSANYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFQSGTDPDIAQVQVQNKLQLATPLLPQEVQQQGISVEKSSSSYLMVAGFVSDNPGTTQDDISDYVASNVKDTLSRLNGVGDVQLFGAQYAMRIWLDADLLNKYKLTPVDVINQLKVQNDQIAAGQLGGTPALPGQQLNASIIAQTRFKNPEEFGKVTLRVNSDGSVVRLKDVARVELGGENYNVIARINGKPAAGLGIKLATGANALDTAKAIKAKLAELQPFFPQGMKVLYPYDTTPFVQLSIHEVVKTLFEAIMLVFLVMYLFLQNMRATLIPTIAVPVVLLGTFAILAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMMEDKLPPKEATEKSMSQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATLLKPVSAEHHENKGGFFGWFNTTFDHSVNHYTNSVGKILGSTGRYLLIYALIVAGMVVLFLRLPSSFLPEEDQGVFLTMIQLPAGATQERTQKVLDQVTDYYLKNEKANVESVFTVNGFSFSGQAQNAGMAFVSLKPWEERNGDENSAEAVIHRAKMELGKIRDGFVIPFNMPAIVELGTATGFDFELIDQAGLGHDALTQARNQLLGMAAQHPASLVSVRPNGLEDTAQFKLEVDQEKAQALGVSLSDINQTISTALGGTYVNDFIDRGRVKKLYVQADAKFRMLPEDVDKLYVRSANGEMVPFSAFTTSHWVYGSPRLERYNGLPSMEIQGEAAPGTSSGDAMALMENLASKLPAGIGYDWTGMSYQERLSGNQAPALVAISFVVVFLCLAALYESWSIPVSVMLVVPLGIVGVLLAATLFNQKNDVYFMVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGVVEATLMAVRMRLRPILMTSLAFILGVLPLAISNGAGSGAQNAVGIGVMGGMVSATLLAIFFVPVFFVVIRRCFKG	4.74	gnl|BL_ORD_ID|1351|hsp_num:0	1437	True	loose hit with at least 95 percent identity pushed strict
scaffold_6_2362 # 2114683 # 2114820 # 1 # ID=6_2362;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.486	scaffold_6_2362 	2114683	2114820	+	Strict	1200	20.0162	tetO	100.0	3000190	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GTGCTCGAGGGTTTATATAGTGAGAACGAAGGGGGCGCGCGTGCTGGCCCTACTAGTCCTGATCCGGCAATCAGTCGTAAAGTTGGATTGTATGGATGGAAATCTTATAAATCAGGCAATAGCTGGGAAGTCAAGTGA	MLEGLYSENEGGARAGPTSPDPAISRKVGLYGWKSYKSGNSWEVK	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMKIPTIFFINKIDQEGIDLPMVYREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIMGNDELLEKYMSGKPFKMSELEQEENRRFQNGTLFPVYHGSAKNNLGTRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEKRRRFVYVRIYSGTLHLRDVIRISEKEKIKITEMYVPTNGELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIENPLPMIQTTIAVKKSEQREILLGALTEISDCDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVEAEIKEPTVIYMERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	7.04	gnl|BL_ORD_ID|1905|hsp_num:0	2020	True	loose hit with at least 95 percent identity pushed strict
scaffold_7_1656 # 1527617 # 1527757 # -1 # ID=7_1656;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.369	scaffold_7_1656 	1527617	1527757	-	Strict	800	20.7866	OprN	100.0	3000805	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGTTATTATGACTGATTATTGTGTGAAGGTTTGTCTTTGTCTGAATATCAATATTGACGTGGAATCATTATGGTGGAAGACAAGGTGGTTATTCAAGATGGCTTTGAGATATGCCGGCTTGAAGGTTGTGTATAATTAA	MVIMTDYCVKVCLCLNINIDVESLWWKTRWLFKMALRYAGLKVVYN	MIHAQSIRSGLASALGLFSLLALSACTVGPDYRTPDTAAAKIDATASKPYDRSRFESLWWKQFDDPTLNQLVEQSLSGNRDLRVAFARLRAARALRDDVANDRFPVVTSRASADIGKGQQPGVTEDRVNSERYDLGLDSAWELDLFGRIRRQLESSDALSEAAEADLQQLQVSLIAELVDAYGQLRGAQLREKIALSNLENQKESRQLTEQLRDAGVGAELDVLRADARLAATAASVPQLQAEAERARHRIATLLGQRPEELTVDLSPRDLPAITKALPIGDPGELLRRRPDIRAAERRLAASTADVGVATADLFPRVSLSGFLGFTAGRGSQIGSSAARAWSVGPSISWAAFDLGSVRARLRGAKADADAALASYEQQVLLALEESANAFSDYGKRQERLVSLVRQSEASRAAAQQAAIRYREGTTDFLVLLDAEREQLSAEDAQAQAEVELYRGIVAIYRSLGGGWQPSA	9.75	gnl|BL_ORD_ID|304|hsp_num:0	172	True	loose hit with at least 95 percent identity pushed strict
scaffold_8_418 # 377446 # 377742 # -1 # ID=8_418;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.492	scaffold_8_418 	377446	377742	-	Strict	2000	21.9422	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	100.0	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GTGAGGAGTGATGGGAAGATCTTCGCTACTGCGGGTTGGGATGGAAGGGTTCGCGTTTATGGGACGAAGGGGATAAAGGAATTGGCTGTTTTGAAATGGCATAAGGTGGGGTGTTATTCGGTTGCTTTTGCCGATGTGGTGGATGATGTTTTGAAGGATGAGGGGGAGGGGAATGAGGTGGTGAAGAAATCGTTGTCGTTGACGGTTAAGGAGAATAGGATAGTGAGGGCGAAGACGGCACATTGGATTGCGGTTGGTGGGAAGGATGGGAAGGTTAGTTTATGGGATGTTTATTGA	MRSDGKIFATAGWDGRVRVYGTKGIKELAVLKWHKVGCYSVAFADVVDDVLKDEGEGNEVVKKSLSLTVKENRIVRAKTAHWIAVGGKDGKVSLWDVY	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	8.26	gnl|BL_ORD_ID|2668|hsp_num:0	2914	True	loose hit with at least 95 percent identity pushed strict
scaffold_8_972 # 879567 # 879776 # 1 # ID=8_972;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.476	scaffold_8_972 	879567	879776	+	Strict	450	21.557	rmtH	100.0	3003198	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGCACGGCTGGGACTTCACCAACCCTGTCAACATATACAGTGATACGAGTTTGTTTGCTGCAGGTTGTTGGATCTCACAGAGACGGGAGAAGGTAAAAGTGCCATTCTTATACGACTCTTTCTCCTTTACAAAGACCCAGAAGAATTACGGCACGTATAAGAGGGAACTTCTAGCCGCATGTCGCTGTTCTCAGAGTGGGGTGGGATGA	MHGWDFTNPVNIYSDTSLFAAGCWISQRREKVKVPFLYDSFSFTKTQKNYGTYKRELLAACRCSQSGVG	MTIEQAAADILSSKKYQLLCPDTVVRILTQEWGRHKKPKQAVERTRERLHGICGAYLAPQVEKQASTALAAGDVQKALALHASTRERLDTYPQLYQFVFENNLPARVLDIACGLNPLMLHRQGVASVWGCDIHQGLGNVLTPYAQKHGWDFTFALHDVLCAPVAASGDMALVFKLLPLLEREQPGAALALLRTLDAPVICVSFPTRSLGGRGKGMHQHYATWFEGLVAPHFTVQHHTLIGDELLYRIQPNPA	27.38	gnl|BL_ORD_ID|33|hsp_num:0	41	True	loose hit with at least 95 percent identity pushed strict
scaffold_8_1424 # 1323436 # 1323564 # 1 # ID=8_1424;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.465	scaffold_8_1424 	1323436	1323564	+	Strict	400	20.0162	VatI	100.0	3003987	protein homolog model	n/a	n/a	streptogramin antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	GTGCCATATTGTTCTTGTATATTCTCGATTAGGGAATCTGCGGTGGTTTTGGCGGAGTATCTTCGTGAGGGGAATGGTTGGGAGAAGGAGATAGAGGTGGTGGGTAGGAATGAGGATTCTGGTTTATAG	MPYCSCIFSIRESAVVLAEYLREGNGWEKEIEVVGRNEDSGL	MTGPNPNERYPIPGDNNLQFIKNTITKPNIIAGDYSYYYALNGESFEDQVLYHYEFIGTKLMIGKFCSIASEVRFMMDGGNHRMDGSTFPFNIFGNGWEKFTPSLDQLPIKGDTIIGNDVWIGRRATIMSGVRIGDGAIIAAEAVVVKDVEPYTIVGGNPAKDIRKRYSTEVIQELLDIKWWDCDIEVINQYIGAIVSGDMDLLRKMRQN	20.00	gnl|BL_ORD_ID|2292|hsp_num:0	2523	True	loose hit with at least 95 percent identity pushed strict
scaffold_8_2246 # 2073150 # 2073251 # 1 # ID=8_2246;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.422	scaffold_8_2246 	2073150	2073251	+	Strict	600	19.2458	AAC(3)-Ib/AAC(6')-Ib''	100.0	3002600	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3); AAC(6')	ATGATATTCGATGGTATGCGAATGAGAAATATGGATGGTGTTGAGAGGGTGGAAGATTTGTTTTGGGTGGGTTGGTGGGAAGAGTCACGAATAGATGATTAG	MIFDGMRMRNMDGVERVEDLFWVGWWEESRIDD	MSIIATVKIGPDEISAMRAVLDLFGKEFEDIPTYSDRQPTNEYLANLLHSETFIALAAFDRGTAIGGLAAYVLPKFEQARSEIYIYDLAVASSHRRLGVATALISHLKRVAVELGAYVIYVQADYGDDPAVALYTKLGVREDVMHFDIDPLTNSNDSVTLRLMTEHDLAMLYEWVNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGGGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	9.88	gnl|BL_ORD_ID|194|hsp_num:0	209	True	loose hit with at least 95 percent identity pushed strict
scaffold_9_1312 # 1171755 # 1171958 # -1 # ID=9_1312;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.549	scaffold_9_1312 	1171755	1171958	-	Strict	1200	21.1718	tetB(P)	100.0	3000195	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGGTCCGACCCCCACAGGATTATCGTACATTGCGAAGTCTTGTCAGCCTCATACTACGGCAGCTATTGCTAGAACAGCGCCTCCAACCATCCAAGCCGCATGTCCTGTAACAGCAGCACCATCAGCTGCGCTCGTGCTGCTACTGATCTTGGAAGAGCCCGTGTTTTGTGGTGCTGCCGAACCTGTACCGCTTGACGTTTGA	MGPTPTGLSYIAKSCQPHTTAAIARTAPPTIQAACPVTAAPSAALVLLLILEEPVFCGAAEPVPLDV	MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERKRGITIKSSTISFNWNNVKVNIIDTPGHVDFISEVERSLNSLDGAILVISGVEGIQSQTRILFDTLKELNIPTIIFVNKLDRIGANFNKVFEEIKKNMSNKVVRLQEVYDVGSKAVYIKKLFDTCIINDDAINVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYAREGSLYPVFCGAAAIGLGIEDLLDGICSYFPFASNDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVPNKEIAEKVKKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKPALKTTISAIDKEKNPELFKALTLLAEEDPLLAFAMNDIDKEIYVNLFGEVQMEILSSMLDDLYGIKVEFSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNVSVGSLPKSFQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVFMEALYKAQTVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVENSKEYKMKIASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD	10.28	gnl|BL_ORD_ID|758|hsp_num:0	804	True	loose hit with at least 95 percent identity pushed strict
scaffold_9_1971 # 1842670 # 1842882 # -1 # ID=9_1971;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.451	scaffold_9_1971 	1842670	1842882	-	Strict	300	21.557	AAC(2')-IIa	100.0	3004628	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(2')	ATGACGACTATTTCTTTTCACTTGAACCTGGTTGCACTGGACAGTGCCTACCCGCAAGACACAGCACAAGGCAAACGAAGCATTGCGACGACTGATAAGAAGGCAGAGAAAGGCAGAATTGAGAGAGAGAATGACGAATTGAGTGCATCACTTGATGACTGGTCTGCAGCACACAATTGCATTGTGATGTTTATGTTGGGTGAAATATTGTGA	MTTISFHLNLVALDSAYPQDTAQGKRSIATTDKKAEKGRIERENDELSASLDDWSAAHNCIVMFMLGEIL	MKDRSHDDSMAEVCRNTSENHWLKTDYRTLFRLCPDGRIERENDPDCSPGPRFWLAGCSEGNVFGVRADVPDDIALKLEELASVEPPFTPPAIPKHLERYLSLLGSDGPVTHDLGLIYELPHAQQYPSKARLIGSGSEEGESLMQSWAEDRVPEALFELGFREVADFWTPWCAAVVDGEVASIAFAARLADAGAELGLVTAKAFRGQGFAAAATAGWSRLSALRSRTLFYSTDRDNISSQRVAARLGLRLRGASLRISRA	26.92	gnl|BL_ORD_ID|2266|hsp_num:0	3327	True	loose hit with at least 95 percent identity pushed strict
scaffold_10_585 # 562649 # 562774 # 1 # ID=10_585;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.476	scaffold_10_585 	562649	562774	+	Strict	1050	20.0162	srmB	100.0	3002828	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGATAGAATCGACATGTTGTGGTGGTGGTGGGGGAGCTGAGGATGACGATGAGGGGTCCATTTATCGAAGGAGGGGTAGAGATTTTTCTTGCCCATTTGATATGGATGGTGATGGGATAGGATGA	MIESTCCGGGGGAEDDDEGSIYRRRGRDFSCPFDMDGDGIG	MSIAQYALHDITKRYHDCVVLDRVGFSIKPGEKVGVIGDNGSGKSTLLKILAGRVEPDNGALTVVAPGGVGYLAQTLELPLDATVQDAVDLALSDLRELEAAMREAEAELGESDENGSERELSAGLQRYAALVEQYQARGGYEADVRVEVALHGLGLPSLDRDRKLGTLSGGERSRLALAATLASSPELLLLDEPTNDLDDRAMEWLEDHLAGHRGTVIAVTHDRVFLDRLTTTILEVDSGSVTRYGNGYEGYLTAKAVERERRLREYEEWRAELDRNRGLITSNVARMDGIPRKMSLSVFGHGAYRRRGRDHGAMVRIRNAKQRVAQLTENPVHAPADPLSFAARIDTAGPEAEEAVAELTDVRVAGRLAVDSLTIRPGERLLVTGPNGAGKSTLLRVLSGELEPDGGSVRVGCRVGHLRQDETPWAPGLTVLRAFAQGREGYLEDHAEKLLSLGLFSPSDLRRRVKDLSYGQRRRIEIARLVSDPMDLLLLDEPTNHLTPVLVEELEQALADYRGAVVVVTHDRRMRSRFTGARLTMGDGRIAEFSAG	7.45	gnl|BL_ORD_ID|113|hsp_num:0	128	True	loose hit with at least 95 percent identity pushed strict
scaffold_11_1011 # 889385 # 889492 # -1 # ID=11_1011;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.435	scaffold_11_1011 	889385	889492	-	Strict	400	19.2458	VatI	100.0	3003987	protein homolog model	n/a	n/a	streptogramin antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	GTGCTTTTCGTTGTAGGTTTGTTGTCGGTGCCATTTTTGATCTTGTCAGTTTTTTCTCCTGGTTTGAGAGGTGTTTGTTGGTGGGATTGTGGAGGAGGAGTGAGGTGA	MLFVVGLLSVPFLILSVFSPGLRGVCWWDCGGGVR	MTGPNPNERYPIPGDNNLQFIKNTITKPNIIAGDYSYYYALNGESFEDQVLYHYEFIGTKLMIGKFCSIASEVRFMMDGGNHRMDGSTFPFNIFGNGWEKFTPSLDQLPIKGDTIIGNDVWIGRRATIMSGVRIGDGAIIAAEAVVVKDVEPYTIVGGNPAKDIRKRYSTEVIQELLDIKWWDCDIEVINQYIGAIVSGDMDLLRKMRQN	16.67	gnl|BL_ORD_ID|2292|hsp_num:0	2523	True	loose hit with at least 95 percent identity pushed strict
scaffold_12_1548 # 1441038 # 1441163 # -1 # ID=12_1548;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.484	scaffold_12_1548 	1441038	1441163	-	Strict	650	19.631	vanO	100.0	3002913	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	GTGGTTACCATGTTAGGTGAGACTGAGGCTGAGGACACGTGGATGAACAGTTTTCGCAATGAGTGTCTTTGTGATGGACCAGATGTGCGATGTGGACAGGCTGTAATGAGTGACAGGAATGAATGA	MVTMLGETEAEDTWMNSFRNECLCDGPDVRCGQAVMSDRNE	MSRLKVGVIFGGASEEHPVSIKSAREVARSLDTEKYEPFWIGITTGGEWKLCDGPDADWENRSARPAVLSPDRSVHGLLVMEQGGYETVRLDLVFPVLHGKLGEDGAIQGLLELAGIPYVGCDIQGSAVCMDKALAYIVAKSAGIATPSFWVVAENEKVDADHLRYPVFVKPARSGSSFGVSKVTREDELPNALSAARQYDSKVLIEEAVAGSEIGCAVMGELFGLITGEVDRVDLSHGFFRIHQEDSPETGSENSTFIVPADISDESRRLVQETAKAIYRTLGCKGLARVDMFLTDDGRVVLNEVNTMPGMTSYSRYPRMMAAAGLPISDMIDRLISMTMHGKKR	11.85	gnl|BL_ORD_ID|1653|hsp_num:0	1754	True	loose hit with at least 95 percent identity pushed strict
scaffold_13_46 # 45015 # 45185 # 1 # ID=13_46;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.485	scaffold_13_46 	45015	45185	+	Strict	2000	21.1718	Staphylococcus aureus mupB conferring resistance to mupirocin	100.0	3000510	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGACCACGAGCTTGAAGGTTGCGCTTCAGGTCCATGTGGACGACTTCATTGAAGTCAGCTTCGTACCGAATAGGTTCGGACGAATAGGTGTCCTGGCTATTTGCTGGAGATGTGACATAGATGAAGGTGTATCTATATCCTTTGGGCAGCTCGCTGAGAACTGGGTATAG	MTTSLKVALQVHVDDFIEVSFVPNRFGRIGVLAICWRCDIDEGVSISFGQLAENWV	MENENIIEEQKILNFWKEENIFKKSIDNRKNDNPFVFYDGPPTANGLPHTGHVLGRVIKDLFARYKTMQGFYVERKAGWDTHGLPVELGVEKKLGIKDKNEIEKYGIEKFINECKNSVFMYEKQWREFSELIGYWVDMEKPYKTMDNTYIESIWYILSDFHKKGLLYKGHKVTPYCPSCETSLSSHEVAQGYKEVKDISVILKFPILDSDENFLVWTTTPWSLPGNIALAINAEEIYVKVNYDNEIFIIMESLLQSVFKDEDNIDIVSKHKGKEFVGKEYLAPFPNKSLMNNENSYKVLPADFVTNKDGTGIVHIAPAYGEDDYKLVQENNIPFINVIDSRGKYNQDSPIFKGELAKESDINIIKELTHLNLLFKKEKYEHSYPFCWRCDNPLIYYAMEGWFIKTTAYKNEIKENNQKIEWYPDHIKNGRFGNFLDNMIDWNIGRKRYWGTPLNIWKCSTCSHEFSPKSINDLIQHSIEDIPSDIELHRPYIDNVKCKCQNCGGDMCREEEVIDVWFDSGSMPFAQNHYPFSGPIQNSYPADFIAEGVDQTRGWFYSLLVISTIFKGEAPYKNALSLGHILDSNGQKMSKSKGNVIDPISMIKTYGADSLRWTLVSDSVPWTNKRFSENMVAQSKSRVIDTLKNIFNFYNMYQKIDNYDYTRDTPKQLNLLDNWAISRMNSVIKEVELHLEKYNPTNASRAIGEFINEISNWYIRRSRSRFWSSEMNEDKKSAYFTLRLILINTCKIIAPFTPFTSEEIHLNLTKKSVHLEDFPQAKEEYINLKLEEDMNKVLDIVEKSRSIRNNINIKTKQPLSNMYIYDNNNLDNEFLRKYKDIIKDEINVKKINIVSDLDNFLEYDVKPNFSTLGPKLGKDMKQFQILFKNIKKEEMNKLINDFDKLQKVFDSLGVTIEEKDFIISKIPKKGFSLSSNDSDRLIILDTNLTQELIREGFVRELIRVIQQLRKQQNFNIEERINVVIDIDSDGLLSIKNNINILKENVLINNLKFEKRETMKYFKINQKEIGIQLMSSFTN	5.42	gnl|BL_ORD_ID|2124|hsp_num:0	2271	True	loose hit with at least 95 percent identity pushed strict
scaffold_14_153 # 144427 # 144594 # -1 # ID=14_153;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.357	scaffold_14_153 	144427	144594	-	Strict	940	20.7866	mdsC	100.0	3000791	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGAGGGGTTGTATGTATATATTATGGTGGATGGAGGGAGTATGTATATATTTGCATGATGAAAAATTGTCTATATCTTGATGATGAAAATGATATCGCTCACCACGAGCTGAATCTCTGCACAATGAAACTTAGAACTTTATCCTGGAAGGATTTTCATTTGTAA	MGGVVCIYYGGWREYVYICMMKNCLYLDDENDIAHHELNLCTMKLRTLSWKDFHL	MRTALIRMISKHNDGNGIMKITFTGYRQTATLATLAFVTTLAGCTMAPKHERPASPTAMVYPYATSTVSGAPDAADIGWRDFFHDPLLQELIAIALRNNRDLRKAGLNVEAARALYRIQRAEMLPTLGIATAMDASRTPADLSVMDESEINRRYEAAGATTAWELDLWGRVRSLSDQALAAYMALDETYIAARMSLVSEVASAWLTLRADRELLRLTEDTLAAQKSSYTLTTQLARTGNATQLDLRMAEIALRSAEINRAAYTRQLARDRNALELLLGQPLTPELSRRLNEAVTLTEGAIPTTLPGGLPSDLLVRRPDIRAAEYRLRGANARIGAARAAFFPTISLTGSAGTASASLSGLFEPGSGSWRFLPQITLPLFHGGALRADLDRAHVQKQIEIARYENVIQQAFRDVADGLAGQRTLNDQVQSEQRAVEASQIAYELAGLRFQEGVDDYLTLLDTHRMLYGAQQRLVRTRLMQQLNIINLYKALGGGWREYSEKKQG	10.93	gnl|BL_ORD_ID|1113|hsp_num:0	1180	True	loose hit with at least 95 percent identity pushed strict
scaffold_14_713 # 669789 # 669908 # -1 # ID=14_713;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.367	scaffold_14_713 	669789	669908	-	Strict	550	22.3274	KPC-40	100.0	3005372	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam	antibiotic inactivation	KPC beta-lactamase	GTGGGTTGTATGATTTTTGGTTTTGGGGGTTTGCGTTGGGAGTTGGAATTGGAGTTGTTTGGTTTTTTTTGTCATGAGTTATTAGAGTTCAGGATCTATTATCCAGAATATCGATATTGA	MGCMIFGFGGLRWELELELFGFFCHELLEFRIYYPEYRY	MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGSANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ	13.22	gnl|BL_ORD_ID|3141|hsp_num:0	4105	True	loose hit with at least 95 percent identity pushed strict
scaffold_15_460 # 386561 # 386923 # -1 # ID=15_460;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.452	scaffold_15_460 	386561	386923	-	Strict	2090	23.0978	mdsB	100.0	3000790	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGATCCGTCGGGCAGGACTGTCACTCTTCGAGGAATAAACATGGCAGGCGATGCTAAATATCCGAGCAATCCAGATCAGCCATCGCATATCCCAGACGGTTTTATAGAAGGTGCAGATTTCGTCAATTTTCGTTCCAGACCTTTCCCAAAAGAAGATGCCCATCTACATTTCTCGAGACTGAAGCGTTGGGGCTACAATACTATCAGATACGTTTTCACTTGGGAAGCAATAGAGGCTGCTGGGCCTGGGAAATATGATGAAGAATGGATTCAGCACACCCTTGAGATACTGAGGCTAGGGAAGGATTACGGATTTTACATATTTATGGATCCTCACCAGGATGTGGTATGTCAATCCTAA	MDPSGRTVTLRGINMAGDAKYPSNPDQPSHIPDGFIEGADFVNFRSRPFPKEDAHLHFSRLKRWGYNTIRYVFTWEAIEAAGPGKYDEEWIQHTLEILRLGKDYGFYIFMDPHQDVVCQS	MKFTHFFIARPIFAIVLSLLMLLAGAIAFLKLPLSEYPAVTPPTVQVSASYPGANPQVIADTVAAPLEQVINGVDGMLYMNTQMAIDGRMVISIAFEQGTDPDMAQIQVQNRVSRALPRLPEEVQRIGVVTEKTSPDMLMVVHLVSPQKRYDSLYLSNFAIRQVRDELARLPGVGDVLVWGAGEYAMRVWLDPAKIANRGLTASDIVTALREQNVQVAAGSVGQQPEASAAFQMTVNTLGRLTSEEQFGEIVVKIGADGEVTRLRDVARVTLGADAYTLRSLLNGEAAPALQIIQSPGANAIDVSNAIRGKMDELQQNFPQDIEYRIAYDPTVFVRASLQSVAITLLEALVLVVLVVVMFLQTWRASIIPLVAVPVSLVGTFALMHLFGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHISQGKSPGEAAKKAMDEVTGPILSITSVLTAVFIPSAFLAGLQGEFYRQFALTIAISTILSAINSLTLSPALAAILLRPHHDTAKADWLTRLMGTVTGGFFHRFNRFFDSASNRYVSAVRRAVRGSVIVMVLYAGFVGLTWLGFHQVPNGFVPAQDKYYLVGIAQLPSGASLDRTEAVVKQMSAIALAEPGVESVVVFPGLSVNGPVNVPNSALMFAMLKPFDEREDPSLSANAIAGKLMHKFSHIPDGFIGIFPPPPVPGLGATGGFKLQIEDRAELGFEAMTKVQSEIMSKAMQTPELANMLASFQTNAPQLQVDIDRVKAKSMGVSLTDIFETLQINLGSLYVNDFNRFGRAWRVMAQADAPFRMQQEDIGLLKVRNAKGEMIPLSAFVTIMRQSGPDRIIHYNGFPSVDISGGPAPGFSSGQATDAIEKIVRETLPEGMVFEWTDLVYQEKQAGNSALAIFALAVLLAFLILAAQYNSWSLPFAVLLIAPMSLLSAIVGVWVSGGDNNIFTQIGFVVLVGLAAKNAILIVEFARAKEHDGADPLTAVLEASRLRLRPILMTSFAFIAGVVPLVLATGAGAEMRHAMGIAVFAGMLGVTLFGLLLTPVFYVVVRRMALKRENRVDSHDQQA	11.37	gnl|BL_ORD_ID|1301|hsp_num:0	1385	True	loose hit with at least 95 percent identity pushed strict
scaffold_16_924 # 826317 # 826517 # -1 # ID=16_924;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.453	scaffold_16_924 	826317	826517	-	Strict	400	21.557	catA4	100.0	3004657	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGGATGTGGCAAGTCAATTGTTGATCTCTCTGTTCAATTTATTTAGGTGCATTGGTGAGAATTTTTTTGGTGTGAAAGGGGTGTATTGTGATGAGGGTTGCGCTGGTGGTGTAATTTTGAGAACTGTGTTGATGGAAGGTGGGATGGGATGCAGAAGAGATGGATGGTGCCTGTCTTGTCGGGTATTCCTCGGTCGGTGA	MDVASQLLISLFNLFRCIGENFFGVKGVYCDEGCAGGVILRTVLMEGGMGCRRDGWCLSCRVFLGR	MDTKRVGILVVDLSQWGRKEHFEAFQSFAQCTFSQTVQLDITSLLKTVKQNGYKFYPTFIYIISLLVNKHAEFRMAMKDGELVIWDSVNPGYNIFHEQTETFSSLWSYYHKDINRFLKTYSEDIAQYGDDLAYFPKEFIENMFFVSANPWVSFTSFNLNMANINNFFAPVFTIGKYYTQGDKVLMPLAIQVHHAVCDGFHVGRLLNEIQQYCDEGCK	30.41	gnl|BL_ORD_ID|2252|hsp_num:0	3357	True	loose hit with at least 95 percent identity pushed strict
scaffold_17_407 # 420057 # 420194 # 1 # ID=17_407;partial=00;start_type=GTG;rbs_motif=AGxAG;rbs_spacer=5-10bp;gc_cont=0.442	scaffold_17_407 	420057	420194	+	Strict	1800	20.0162	MexD	100.0	3000801	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; penam; tetracycline antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAATATGGATCCATTTCATCCTACATCCCACATGCTTTATGTGGAAATTGAACAACGTGATCCAGATCCAGATCCACTTTTCGAGGCTTCCATACTATGGGTGATAACACAGGTGCCTCGGTTAGTCGTTCACTAG	MNMDPFHPTSHMLYVEIEQRDPDPDPLFEASILWVITQVPRLVVH	MSEFFIKRPNFAWVVALFISLGGLLVISKLPVAQYPNVAPPQITITATYPGASAKVLVDSVTSVLEESLNGAKGLLYFESTNNSNGTAEIVVTFEPGTDPDLAQVDVQNRLKKAEARMPQAVLTQGLQVEQTSAGFLLIYALSYKEGAQRSDTTALGDYAARNINNELRRLPGVGKLQFFSSEAAMRVWIDPQKLVGFGLSIDDVSNAIRGQNVQVPAGAFGSAPGSSAQELTATLAVKGTLDDPQEFGQVVLRANEDGSLVPARRCRAPGTRQGELQHFLATERHAHRGRGYPAVARGQRDPDPTLVKQRLAELSAFFPEDMQYSVPYDTSRFVDVAIEKVIHTLIEAMVLVFLVMFLFLENVRYTLIPSIVVPVCLLGTLMVMYLLGFSVNMMTMFGMVLAIGILVDDAIVVVENVERIMAEEGISPAEATVKAMKQVSGAIVGITLVLSAVFLPLAFMAGSVGVIYQQFSVSLAVSILFSGFLALTFTPALCATLFKPIPEGHHEKRGFFGAFNRGFARVTERYSLLNSKLVARAGRFMLVYAGLVAMLGYFYLRLPEAFVPAEDLGYMVVDVQLPPGASRVRTDATGEELERFLKSREAVASVFLISGFSFSGQGDNAALAFPTFKDWSERGAEQSSAAEIAALNEHFALPDDGTVMAVSPPPINGLGNSGGFALRLMDRSGVGREALLQARDTLLGEIQTNPKFLYAMMEGLAEAPQLRLLIDREKARALGVSFETISGTLSAAFGSEVINDFTNAGRQQRVVIQAEQGNRMTPESVLELYVPNAAGNLVPLSAFVSVKWEEGPVQLVRYNGYPSIRIVGDAAPGFSTGEAMAEMERLASQLPAGIGYEWTGLSYQEKVSAGQATSLFALAILVVFLLLVALYESWSIPLSVMLIVPIGAIGAVLAVMVSGMSNDVYFKVGLITIIGLSAKNAILIVEFAKELWEQGHSLRDAAIEAARLRFRPIIMTSMAFILGVIPLALASGAGAASQRAIGTGVIGGMLSATFLGVLFVPICFVWLLSLLRSKPAPIEQAASAGE	4.31	gnl|BL_ORD_ID|1525|hsp_num:0	1523	True	loose hit with at least 95 percent identity pushed strict
scaffold_17_554 # 561274 # 561390 # -1 # ID=17_554;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.521	scaffold_17_554 	561274	561390	-	Strict	700	20.0162	Tet(47)	100.0	3004613	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGGAGGAGGAGAGGTTTTGGGTGGTTGTTTGCCATTTTCGTTGCGTGGAATTTGGGGCTGCGTTTGGTTGGGGTTCTGCTTCTGGAGTAGGTGAGTATGGAGAGGACTTGGTCTGA	MEEERFWVVVCHFRCVEFGAAFGWGSASGVGEYGEDLV	MRCHFRCNLALPLLVFLNLSRAIKDYQTMSSINNILVIGAGIAGPSVCYWLKRFGFSPVLIEKSANLRKGGHALDVRGVAIDLVKRMGIYEKIGNRRTQVEFGRYMDTQGNILHEEKGERFCYREGEDVEITRGDLVEILIDAIEGVPCYLNQSIDSIKQRDGDVAVRFKDGKIEYYDLIIGADGLHSTTRRMVFDKDEYQLTNLGAYFSVFSIPNYLNLNHTEIQFEANQKLISMTSDKNPKMAEVAFMFRVQNVLNNRRDENEQKRFLRDTFQGFGWETSKILELMSDSDDFYFDSVSQVKMKSWTKGRVALLGDAGYCASPISGQGNNLALVGAYVLAGELKQASDNYHQAFNRYNELLHPFIEANQKLGVLVNESFLVQDEVSKEVAEERSNKIMEEVKIVSNMISLPDYE	9.16	gnl|BL_ORD_ID|2129|hsp_num:0	3308	True	loose hit with at least 95 percent identity pushed strict
scaffold_20_17 # 16245 # 16349 # 1 # ID=20_17;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.495	scaffold_20_17 	16245	16349	+	Strict	900	19.631	ANT(3'')-Ii-AAC(6')-IId fusion protein	100.0	3002598	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6'); ANT(3'')	GTGGGGACGTGGGGACGTGGGGAGGACTGTGCCGATGGATCTGATAGGAGACTAGATAGAGGGGAGACGAAAGTGTGTGATGATTTTAGTTGTTATATACCTTGA	MGTWGRGEDCADGSDRRLDRGETKVCDDFSCYIP	MSNAVPAEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAQLDETVRQALVVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPARRELQFGEWQRKDILAGIFEPATTDVDLAILLTKVRQHSLALAGSAAEDFFNPVPEGDLFKALSDTLKLWNSQPDWEGDERNVVLTLSRIWYSAATGKIAPKDIVANWAIERLPDQHKPVLLEARQAYLGRGEDCLASRADQLAAFVHFVKHEATKLLGAMPVMSKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	7.34	gnl|BL_ORD_ID|2045|hsp_num:0	339	True	loose hit with at least 95 percent identity pushed strict
scaffold_20_357 # 311716 # 312048 # -1 # ID=20_357;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.480	scaffold_20_357 	311716	312048	-	Strict	450	22.3274	aadA4	100.0	3002604	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	ATGGGTATGATCAAGTCTGCTGGCTCCACCGTTTCCTGGCTGGTGAAAAACGTTGCTGTGAGCGTCGTGTTATACAGCCCGGTGTATGTGCTGTCCACAAGATTACCCAGGTCGAAGATGAGCTTTTGGGGTGATTTCCAGATCGACAGGAACTCGGACATATCTTTGATGTATTCCCATCTAATACCATTTGCAGTGGGCTCCGCGGTAGAAGTCCGCCAAACTTCGGTATCGTTGAAATACATCAGCGCGAGTCTGTCAAACTGGCGACCTTTGGAGGTAACAGTGAAATTCATGCTGACTCTGTTGAAGTCGCAATTTGGAGGAGTATAA	MGMIKSAGSTVSWLVKNVAVSVVLYSPVYVLSTRLPRSKMSFWGDFQIDRNSDISLMYSHLIPFAVGSAVEVRQTSVSLKYISASLSNWRPLEVTVKFMLTLLKSQFGGV	MGEFFPAQISEQLSHARGVIERHLAATLDTIHLFGSALDGGLKPDSNIDLLVTVSAAPNDSLRQALMLDLLKVSSPPGNGGPWRPLEVTVVARSEVVPWRYPARRGLQFGEWLRHDILSGTFEPAVLDHDLAILLTKARQHSLALLGPSAVTFFEPVPNEHFSKALFDTIAQWNSESDWKGDERNVVLALARIWYSASTGLIAPKDVAAAWVSERLPAEHRPIICKARAAYLGSEDDDLAMRVEETAAFVRYAKATIERILR	41.98	gnl|BL_ORD_ID|105|hsp_num:0	120	True	loose hit with at least 95 percent identity pushed strict
scaffold_24_433 # 425120 # 425377 # -1 # ID=24_433;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.531	scaffold_24_433 	425120	425377	-	Strict	340	21.557	sta	100.0	3004699	protein homolog model	n/a	n/a	nucleoside antibiotic	antibiotic inactivation	streptothricin acetyltransferase (SAT)	ATGTCCGTGTTCGGGTTGAGCGCTGGGGCAGATATCCACGCGTTCGGCAAAGGTTGTATTCGGCGAACGGCGCTTGGAGCTGCCATCTGCCACGGTCGCTTCGATATAGTCTATCTCTTGCTTGAGGCTGGAGCTGGTGTGTATGAGCATGGGGGCGGTAATAACAAAGATACCAAGGCTGCTGACTTTGCGCGGGAGAGGGGTCACATTGCTATTGCTGAGATGATTGAAGAGTGGGAAGTGTCTCATAGCAGTTGA	MSVFGLSAGADIHAFGKGCIRRTALGAAICHGRFDIVYLLLEAGAGVYEHGGGNNKDTKAADFARERGHIAIAEMIEEWEVSHSS	MTTTHGSTYEFRSARPGDAEAIEGLDGSFTTSTVFEVDVTGDGFALREVPADPPLVKVFPDDGGSDGEDGAEGEDADSRTFVAVGADGDLAGFAAVSYSAWNQRLTIEDIEVAPGHRGKGIGRVLMRHAADFARERGAGHLWLEVTNVNAPAIHAYRRMGFAFCGLDSALYQGTASEGEHALYMSMPCP	44.97	gnl|BL_ORD_ID|2281|hsp_num:0	3397	True	loose hit with at least 95 percent identity pushed strict
scaffold_25_364 # 378042 # 378179 # -1 # ID=25_364;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.435	scaffold_25_364 	378042	378179	-	Strict	2200	20.0162	Bifidobacterium bifidum ileS conferring resistance to mupirocin	100.0	3003730	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	GTGGGTCTTGGAGTTGGGAGGAGTGTTGGTTGTGGTGATTACCCGCGAGACTTCGTATATATAAAAGGGGTACTGGATTGGATTGGACTTCTTTCTTTGTCTTTCCATAGATCAGACAAGGGGAATAGGATATTTTGA	MGLGVGRSVGCGDYPRDFVYIKGVLDWIGLLSLSFHRSDKGNRIF	MSETTNSHVYPKANEGGETASVAPNPSFPNMEETVLKYWDKDDTFNKSVERNPSGDHSQNEFVFFDGPPFANGLPHYGHLLTGYAKDVIPRYQTMKGRKVNRVFGWDTHGLPAELEAQKELGIDSVDQIEKMGIDKFNDACRASVLKYTHEWQDYVHRQARWVDFEHGYKTLNIPYMESVMWAFKQLYEKGLAYQGYRVLPYCPKDQTPLSAHELRMDADVYQDRQDTTVSVAVKLRDEEDAYAVFWTTTPWTVPTNFAIVVGADIDYVEVRPTQGKYAGKKFYFGKPLLSKYEKELGEDYEVVRELKGSEMAGWRYWPVFPYFAGDKAESEGNVPGPEGYQIFTADYVDTVEGTGLVHQAPYGEDDMNTLNAHGIKSTDVLDAGCRFTAQCPDYEGMYVFDANKPILRNLRNGDGPLAEIPAEHRAILFQEKSYVHSYPHCWRCATPLIYKPVSSWFVSVTKIKPRLLELNQQINWIPENVKDGQFGKWLANARDWSISRNRFWGSPIPVWVSDDPKYPRVDVYGSLEELKADFGDYPRDKDGNVNMHRPWIDNLTRVNPDDPTGKSHMHRISDVLDCWFESGSMSFAQFHYPFENKEKFEQHFPADYIVEYIGQTRGWFYLLHVMATALFDRPAFKNVICHGIVLGSDGQKMSKHLRNYPDVNGVFDKYGSDAMRWFLMSSPILRGGNLIVTAEGIRDTVRQVMLPVWSSYYFFTLYANAANGGAGFDARQLRADEVAGLPEMDRYLLARTRRLVERVEKSLDEFAISDACDAASDFIDVLTNWYIRNTRDRFWKEDVNAFNTLYTVLEVFMRVLAPLAPMESESVWRGLTGGESVHLADWPYVADEKTGEATELGRVLVDDPALVDAMEKVREIVSGALSLRKAAQIRVRQPLAKLTVVVEDVDAVKAYDEILKSELNIKDIEFCTMEDAGSQGLKIVHELKVNARAAGPRLGKQVQFAIKASKTGAWHVDAATGAPVVETPNGEVALEAGEYELINRVEEENAAEADASVSAALPTGGFVILDTVLTADLEAEGYARDVIRAVQDARKAADLDIADRIALVLTVPSANVADVERFRDLIAHETLATSFAVKEGAELGVEVAKA	4.07	gnl|BL_ORD_ID|2107|hsp_num:0	2278	True	loose hit with at least 95 percent identity pushed strict
scaffold_26_213 # 209428 # 209541 # -1 # ID=26_213;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.456	scaffold_26_213 	209428	209541	-	Strict	400	19.631	vanRA	100.0	3002919	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGTTTTGGGAGCTGTTTGTGTTTGATGGAGGATCTTGTGATGGTTTGGTGAGAGGTTTGGTGAGAGAATGGGTAGTGTTTCTGGTAGTGTGGGGAGTAGGGTATGTTTGTTGA	MFWELFVFDGGSCDGLVRGLVREWVVFLVVWGVGYVC	MSDKILIVDDEHEIADLVELYLKNENYTVFKYYTAKEALECIDKSEIDLAILDIMLPGTSGLTICQKIRDKHTYPIIMLTGKDTEVDKITGLTIGADDYITKPFRPLELIARVKAQLRRYKKFSGVKEQNENVIVHSGLVINVNTHECYLNEKQLSLTPTEFSILRILCENKGNVVSSELLFHEIWGDEYFSKSNNTITVHIRHLREKMNDTIDNPKYIKTVWGVGYKIEK	16.02	gnl|BL_ORD_ID|680|hsp_num:0	722	True	loose hit with at least 95 percent identity pushed strict
scaffold_28_124 # 111803 # 111892 # 1 # ID=28_124;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=3-4bp;gc_cont=0.500	scaffold_28_124 	111803	111892	+	Strict	1900	19.2458	MexW	100.0	3003031	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; acridine dye; phenicol antibiotic; disinfecting agents and intercalating dyes	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGAGAAAATAATAATGAGGTTGTGGTTGGATGAATGGGGTGAAGGGGAGGGAAGGACGAATTCGAGGTTGGATACGGGAGGGAGGTGA	MEKIIMRLWLDEWGEGEGRTNSRLDTGGR	MAFTDPFIRRPVLASVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQGYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLPPDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQVFAMRLWLDPVKMAAFGVTAGEINQAVQQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAFAAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVRAKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLIPVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKPPFEAALEGAREIAVPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTLSPMMCSRLLRHEENPSGLAHRLDLIFEGLKQRYQRALHGTLDTRPVVLVFAVLVLALIPVLLMFTKKELAPEEDQGIVFLMTNSPQTANLDYLNRYTAEFEGIFRSFPEYYSAFQINGYNGVQAGIGGMLLKPWDEREKSQMELLHAVQAKLNEIPGVQIFAFNLPSLPGTGEGLPFQFVLNTANDYESLLQVAQRVKQRASESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDLGVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSRNGQLVALSTLIETHERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYVQEGSALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALIPLFLGVSSLNIYTQVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVIPLILATGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAANAH	2.85	gnl|BL_ORD_ID|2063|hsp_num:0	2208	True	loose hit with at least 95 percent identity pushed strict
scaffold_36_3 # 4851 # 5045 # -1 # ID=36_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.482	scaffold_36_3 	4851	5045	-	Strict	550	21.9422	CKO-1	100.0	3004773	protein homolog model	n/a	n/a	penam	antibiotic inactivation	CKO beta-lactamase	ATGAGTGTCGTTGTTATTTACTTAATTATTTTTAGCGAGGTCCATTTCTGGCCTACGTCACAGAAACCCCCCAAAAACCATCTTAGCCCTTCCATATTCTTGGTACTTAAGCGTTGGGAACCGCAGATGGGGTTATCCTGGCAGACGGAGGTTCTTCAAGAAGGAGGGGTGTCGCATGCCGCTGCACCGCAATGA	MSVVVIYLIIFSEVHFWPTSQKPPKNHLSPSIFLVLKRWEPQMGLSWQTEVLQEGGVSHAAAPQ	MRNEEVISMWQRMKWGLCVLAALSGSAMAAPLTAQYVSAIAMQEEQRLHARIGIAVLDTATNSITHYRGEERFPLNSTHKPLLCAALLREVDRKALALSASMQFEPSQLVEYSPITEKHVAPDAMSWAQLCSAAVSYSDNTAANLIARKLNGPQAVTQFLRDSGDTITRLDRYEPELNSAIPGDERDSTTPVAIAQTLNTLLLGNVLQPSSREQLMQWMRDDKVADGLLRSVLPDGWKIADKTGAGDNGSRSIVSVVWPTSQKPLLVVIYITQTPATMAQRDAAIVRIGESLFSTLAVYD	21.33	gnl|BL_ORD_ID|2663|hsp_num:0	3574	True	loose hit with at least 95 percent identity pushed strict
